46.
Clinical presentation, management, and outcomes in the Indian Heart Rhythm Society-Atrial Fibrillation (IHRS-AF) registry
Vora, A. and Kapoor, A. and Nair, M. and Lokhandwala, Y. and Narsimhan, C. and Ravikishore, A. G. and Dwivedi, S. K. and Namboodiri, N. and Hygriv, R. and Saxena, A. and Nabar, A. and Garg, S. and Bardoloi, N. and Yadav, R. and Nambiar, A. and Pandurangi, U. and Jhala, D. and Naik, A. and Nagmallesh and Rajagopal, S. and Selvaraj, R. and Arora, V. and Thachil, A. and Thomas, J. and Panicker, G..
Indian Heart Journal
2017;
69:
43--47
Show abstract
Aim A national atrial fibrillation (AF) registry was conducted under the aegis of the Indian Heart Rhythm Society (IHRS), to capture epidemiological data-type of AF, clinical presentation and comorbidities, current treatment practices, and 1-year follow-up outcomes. Methods A total of 1537 patients were enrolled from 24 sites in India in the IHRS-AF registry from July 2011 to August 2012. Their baseline characteristics and follow-up data were recorded in case report forms and subsequently analyzed. Results The average age of Indian AF patients was 54.7 years. There was a marginal female preponderance – 51.5{\%} females and 48.5{\%} males. At baseline, 20.4{\%} had paroxysmal AF; 33{\%} had persistent AF; 35.1{\%} had permanent AF and 11{\%} had first AF episode. At one-year follow-up, 45.6{\%} patients had permanent AF. Rheumatic valvular heart disease (RHD) was present in 47.6{\%} of patients. Hypertension, heart failure, coronary artery disease, and diabetes were seen in 31.4{\%}, 18.7{\%}, 16.2{\%}, and 16.1{\%}, respectively. Rate control was the strategy used in 75.2{\%} patients, digoxin and beta-blockers being the most frequently prescribed rate-control drugs. Oral anticoagulation (OAC) drugs were used in 70{\%} of patients. The annual mortality was 6.5{\%}, hospitalization 8{\%}, and incidence of stroke 1{\%}. Conclusions In India, AF patients are younger and RHD is still the most frequent etiology. Almost two-third of the patients have persistent/permanent AF. At one-year follow-up, there is a significant mortality and morbidity in AF patients in India.